Research and Development: Page 4

Oxford Nanopore to receive $84.6M investment from BioMĂ©rieux, enters collaboration with Mayo Clinic
By LabPulse.com staff writers
Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMĂ©rieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.
October 19, 2023
Research Money Social
ARUP launches new collaborative research institute
By Matt Limb
ARUP Industries is hoping to “push the boundaries of diagnostic medicine” via the launch of a new research institute that aims to forge collaborations with industry and community partners.
October 18, 2023
Lab Scientist Computer Ai Social
CMS opens new doors for cell and gene therapy under Medicaid
By Liz Carey
A new Medicaid-focused Innovation Center model encourages agreements between pharmaceutical companies and states for cell and gene therapies (CGT).
October 18, 2023
Sickle Cell Anemia2 Social
AI-driven method developed to identify therapeutic targets
By Matt Limb
Researchers have developed a method of identifying therapeutic targets for human diseases associated with protein phase separation that they say could be used to discover targets for Alzheimer’s and other neurogenerative diseases.
October 17, 2023
Artificial Intelligence Brain Social
Twist Bioscience, Bayer enter agreement on antibody discovery and licensing
By LabPulse.com staff writers
Twist Bioscience and Bayer have signed an antibody discovery, option, and licensing agreement.
October 9, 2023
Business Men Handshake Social
Study launched on early intervention with immune modulators in COVID-19
By LabPulse.com staff writers
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
HIV vaccine trial begins enrollment in U.S., South Africa
By LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
By Nick Paul Taylor
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
By LabPulse.com staff writers
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Breast Mammo Social
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
By LabPulse.com staff writers
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
Lab Blood Tubes Social
Moderna’s mRNA flu shot yields promising results in phase III trial
By LabPulse.com staff writers
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Vaccine Injection Woman Social
U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases
By Matt Limb
U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.
September 14, 2023
Money Bag Grant Award Social
Previous Page
Page 4 of 38
Next Page